iDOVE
Durability of Vaccine Efficacy Against SARS-CoV-2 Infection
Implements a nonparametric maximum likelihood method for assessing potentially time-varying vaccine efficacy (VE) against SARS-CoV-2 infection under staggered enrollment and time-varying community transmission, allowing crossover of placebo volunteers to the vaccine arm. Lin, D. Y., Gu, Y., Zeng, D., Janes, H. E., and Gilbert, P. B. (2021)
- Version1.5
- R version≥ 3.5.0
- LicenseGPL-2
- Needs compilation?Yes
- Last release12/13/2023
Documentation
Team
Shannon T. Holloway
Yu Gu
Show author detailsRolesAuthorDan-Yu Lin
Show author detailsRolesAuthor
Insights
Last 30 days
Last 365 days
The following line graph shows the downloads per day. You can hover over the graph to see the exact number of downloads per day.
Data provided by CRAN
Binaries
Dependencies
- Depends1 package
- Imports4 packages
- Suggests2 packages
- Linking To2 packages